Skip to main content
Clinical Trials/CTRI/2011/12/002186
CTRI/2011/12/002186
Completed
Phase 4

Clinical evaluation of dexmedetomidine as an adjuvant to bupivacaine in subarachnoid block for lower abdominal surgery:A randomized double blind controlled study.

Department Of Anasthesiology0 sites100 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Conditions requiring lower abdominal surgery i.e. Inguinal hernia, Open appendicectomy
Sponsor
Department Of Anasthesiology
Enrollment
100
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department Of Anasthesiology

Eligibility Criteria

Inclusion Criteria

  • 1\.Age: 30 to 60 years.
  • 2\.Sex: Male.
  • 3\.Patients posted for lower abdominal surgery; i. e. inguinal hernia repair and open appendicectomy.
  • 4\.Informed written consent for participation in study.
  • 5\.BMI 25 kg/m2\.

Exclusion Criteria

  • 1\. Uncontrolled or labile hypertension.
  • 2\. Contraindication to spinal anaesthesia.
  • 3\. Allergy to local anaesthetic or study drug.
  • 4\. Body mass index \>25 kg/m2\.
  • 5\. Patients taking any analgesics sedative or antihypertensive drugs.
  • 6\. Neurological disorders.
  • 7\. Psychiatric disorders.
  • 8\. Unco\- operative patients.

Outcomes

Primary Outcomes

Not specified

Similar Trials